These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11010596)

  • 21. The current laboratory determination of "respirable mass" is not clinically relevant.
    Newhouse MT
    J Aerosol Med; 1998; 11 Suppl 1():S122-32. PubMed ID: 10180724
    [No Abstract]   [Full Text] [Related]  

  • 22. Towards improved aerosol devices for the young child.
    Bisgaard H
    Pediatr Pulmonol Suppl; 1999; 18():78. PubMed ID: 10093104
    [No Abstract]   [Full Text] [Related]  

  • 23. Special problems in aerosol delivery: neonatal and pediatric considerations.
    Cole CH
    Respir Care; 2000 Jun; 45(6):646-51. PubMed ID: 10894457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How well do in vitro particle size measurements predict drug delivery in vivo?
    Newman SP
    J Aerosol Med; 1998; 11 Suppl 1():S97-104. PubMed ID: 10180741
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
    Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
    Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-of-flight aerodynamic particle size analyzers: their use and limitations for the evaluation of medical aerosols.
    Mitchell JP; Nagel MW
    J Aerosol Med; 1999; 12(4):217-40. PubMed ID: 10724637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to characterise pharmaceutical aerosols: measurement of aerosol from a single dose aqueous inhaler with an optical particle counter.
    Kuhli M; Weiss M; Steckel H
    Eur J Pharm Sci; 2010 Jan; 39(1-3):45-52. PubMed ID: 19874891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosol delivery devices.
    Crompton GK; Barnes PJ
    Chest; 2006 May; 129(5):1388-9; author reply 1389. PubMed ID: 16685035
    [No Abstract]   [Full Text] [Related]  

  • 29. [Measurement of size of aerosols produced by different aerosol generators and effect of physical factors on aerosol size].
    Anazawa Y; Isawa T; Teshima T; Hirano T; Miki M; Konno K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Aug; 26(8):863-7. PubMed ID: 3204867
    [No Abstract]   [Full Text] [Related]  

  • 30. Errors in characterizing nebulized particle size distributions with cascade impactors.
    Stapleton KW; Finlay WH
    J Aerosol Med; 1998; 11 Suppl 1():S80-3. PubMed ID: 10180737
    [No Abstract]   [Full Text] [Related]  

  • 31. Aerosol therapy.
    Hess D
    Respir Care Clin N Am; 1995 Dec; 1(2):235-63. PubMed ID: 9390861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers.
    Asmus MJ; Liang J; Coowanitwong I; Vafadari R; Hochhaus G
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):204-8. PubMed ID: 11868926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerosol delivery to children: what to use, how to choose.
    Dolovich M
    Pediatr Pulmonol Suppl; 1999; 18():79-82. PubMed ID: 10093105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical aerosol electrostatics: a field with much potential for development.
    Lip Kwok PC
    Ther Deliv; 2015 Feb; 6(2):105-7. PubMed ID: 25690079
    [No Abstract]   [Full Text] [Related]  

  • 35. Design and testing of aerosol delivery systems for reproducible clinical performance.
    Cipolla DC; Farr SJ; Gonda I; Herst CV; Lee RY; Lloyd P; McKinley G; Rubsamen R; Schuster J; Zellhoefer C
    J Aerosol Med; 1998; 11 Suppl 1():S84-8. PubMed ID: 10180738
    [No Abstract]   [Full Text] [Related]  

  • 36. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing.
    Restrepo RD; Dickson SK; Rau JL; Gardenhire DS
    Respir Care; 2006 Jan; 51(1):56-61. PubMed ID: 16381619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.
    Golshahi L; Longest PW; Azimi M; Syed A; Hindle M
    Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging aerosol drug delivery strategies: from bench to clinic.
    Rubin BK; Williams RW
    Adv Drug Deliv Rev; 2014 Aug; 75():141-8. PubMed ID: 24993613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols.
    Kim CS; Eldridge MA; Sackner MA
    Am Rev Respir Dis; 1987 Jan; 135(1):157-64. PubMed ID: 3800143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of aerosolized drugs.
    Wolff RK; Niven RW
    J Aerosol Med; 1994; 7(1):89-106. PubMed ID: 10147060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.